Decreased benzodiazepine receptor binding in Machado-Joseph disease.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Nuclear Medicine

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 9744334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Positron emission tomography (PET) in Machado-Joseph disease.

  1997cited by this paper
• Noninvasive quantification of iodine-123-iomazenil SPECT.

  1996cited by this paper
• Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans.

  1995cited by this paper
• CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

  1994cited by this paper
• Abundant reinnervation in peripheral nerves in Joseph disease

  1993cited by this paper
• SPECT Imaging of the benzodiazepine receptor: Autoradiographic comparison of receptor density and radioligand distribution

  1992cited by this paper
• Hereditary neuropathies and spinocerebellar atrophies

  1991cited by this paper
• In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.

  1990cited by this paper
• A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

  1984cited by this paper
• Joseph disease: an autosomal dominant motor system degeneration.

  1984cited by this paper
• Joseph disease: an autosomal dominant motor system degeneration.

  1984cited by this paper
• Selective antagonists of benzodiazepines

  1981cited by this paper
• Autosomal dominant striatonigral degeneration

  1976cited by this paper
• Autosomal dominant striatonigral degeneration: a clinical, pathological, and biochemical study of a new genetic disorder.

  1976cited by this paper

• Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development.

  2021cites this paper
• Spinocerebellar ataxia clinical trials: opportunities and challenges

  2021cites this paper
• Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease.

  2018influential citation
• Assessment of Sleep Spindle Density among Genetically Positive Spinocerebellar Ataxias Types 1, 2, and 3 Patients

  2018cites this paper
• Neuroimaging Applications in Chronic Ataxias.

  2018cites this paper
• Repeated encephalopathy and hemicerebral atrophy in a patient with familial hemiplegic migraine type 1.

  2014cites this paper
• Dopamine Transporter Imaging for Distinguishing Between Idiopathic Parkinson’s Disease and Secondary Parkinsonism

  2012cites this paper
• Magnetic resonance and nuclear medicine imaging in ataxias.

  2012cites this paper
• High-dose zolpidem withdrawal seizure in a patient with spinocerebellar ataxia.

  2011cites this paper
• Participation of the GABAergic system on the glutamate release of frontal cortex synaptosomes from Wistar rats with experimental autoimmune encephalomyelitis.

  2011cites this paper
• b 2 Nicotinic acetylcholine receptor availability in post-traumatic stress disorder

  2008cites this paper
• Radiolysis of an aqueous [11C]iomazenil solution

  2004cites this paper
• Diagnostic Evaluation of Ataxic Patients

  2003cites this paper
• Radioligantes para neurorreceptores benzodiazepínicos

  2003cites this paper
• Brain single-photon emission computed tomography and magnetic resonance imaging in Machado-Joseph disease.

  2001cites this paper
• Decreased Dopamine TransporterBinding in MachadoJoseph Disease

  2000cites this paper
• 17 – Neurodegenerative Disorders of the Cerebellum

  2000cites this paper
• Decreased dopamine transporter binding in Machado-Joseph disease.

  2000cites this paper
• Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: The optimal scan time

  1996cites this paper